CMS’s CRUSH proposed rule would increase fraud oversight across federal programs
The rule would expand Medicare Advantage provider enrollment requirements, revise risk adjustment audits and tighten Medicaid payment oversight.
A new rule from CMS would heighten federal oversight of fraud, waste and abuse issues in Medicare and Medicaid, among other programs.
As described in the proposed rule, also known as the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), the agency estimates the proposals could have a $90 billion impact over a decade. The figure represents expected transfers between the federal government, states and private entities, not necessarily net savings to the government or the healthcare system. It has not yet been subject to an assessment by the CMS Actuary.
Comments on the rule are due Jan. 19 at Regulations.gov.
Improper payment rates rise in Medicare and Medicaid but fall in MA
In conjunction with the proposed rule, CMS released a fact sheet on FY26 improper payments in government healthcare programs.
On a percentage basis, estimated improper payments increased year over year for Original Medicare and Medicaid while declining for Medicare Advantage (MA), Medicare Part D and advance premium tax credits in the Affordable Care Act marketplaces.
Rather than suggesting actual fraud or abuse, “Most improper payments occurred in situations where a reviewer could not determine if a payment was proper because of insufficient documentation from a state, provider, a Medicare Advantage organization, Part D sponsor or marketplace insurer,” CMS wrote.
Medicaid’s estimated improper payments totaled $46.8 billion, the most of any program. CMS attributes more than 79% of those instances to documentation issues.
While estimated improper payments in Original Medicare rose by $5.1 billion, CMS said the statistics do not reflect the full impact of newer program-integrity initiatives, including enrollment moratoria for provider types deemed as high-risk (e.g., home health agencies and hospices) and large-scale provider and supplier enrollment revocations and payment suspensions in response to suspicious billing patterns.
One initiative for providers to anticipate in Original Medicare is ClaimsCore, described in the fact sheet as a pending “best-in-class commercial claims-processing effort that will re-platform Original Medicare claims processing onto a secure, configurable and modern foundation.”
CMS proposes new Medicare enrollment requirements for MA providers
Per the CRUSH proposed rule, both in-network and out-of-network providers would need to be approved for enrollment in Original Medicare as a prerequisite to bill MA health plans. The agency estimates that roughly 150,000 MA providers would need to enroll to fulfill the requirement and projects an effective date of Jan. 1, 2030.
The rule also would establish a uniform 30-day deadline for providers to report changes in enrollment information, whereas some changes currently can be reported within 90 days.
CMS also would be authorized to deny or revoke Medicare enrollment either when the identity of a provider organization’s owner or managing employee cannot be verified or following a change in majority ownership if the agency determines that the change presents an undue risk of fraud or abuse.
MA and Medicare Part D plans would need to report suspected or substantiated fraud, waste and abuse, rather than having the choice to do so. CMS indicated the change is necessary because only 46% of MA and Part D plan contracts voluntarily reported fraud referrals in 2025.
RADV audit changes target billions in Medicare Advantage overpayments
The MA Risk Adjustment Data Validation (RADV) audit program, which examines whether medical records support submitted diagnoses for payment purposes, would undergo several technical and methodological changes. In a fact sheet, CMS stated that the changes would enable recovery of roughly $9 billion per year in MA overpayments.
In the separate fact sheet on improper payments, CMS said diagnosis documentation remains a major vulnerability even as the MA improper payment rate dropped from 6.09% to 5.68% from 2025 to 2026.
Although RADV audits primarily target health plans, hospitals and physician groups may see increased requests for documentation. CMS’s audit framework examines whether diagnoses submitted for risk adjustment are supported by medical records, including from inpatient and outpatient hospital units and from physicians.
Medicaid proposals tighten payment suspensions and overpayment reporting
State Medicaid agencies would have leeway under the proposed rule to rely on a credible fraud determination by CMS or other federal agencies as the basis for suspending payments to providers.
Circumstances allowing for good-cause exceptions would be narrowed, and the exceptions would need to be documented and reported to CMS on a case-by-case basis. CMS wrote in the rule that 75% of credible fraud allegations in 2025 did not result in payment suspensions because states used a good-cause exception.
“The data suggests that some states may be invoking the exception as a blanket policy to avoid provider abrasion, administrative burden or litigation risk, rather than on a case-by-case basis as required,” CMS wrote.
Regulations also would require self-identified overpayments by Medicaid fee-for-service providers to be reported and returned within 60 days, consistent with existing requirements in other programs. The obligation could extend to scenarios where a provider has not acknowledged an overpayment if CMS can establish reckless disregard or deliberate ignorance.
Expanded Medicaid enrollment denial and termination authority would mirror existing Medicare provisions, with criteria including certain felony convictions and abusive billing or prescribing practices. States would be newly authorized to maintain suspensions of a provider’s enrollment even when law enforcement declines to investigate the fraud referral.
Providers would be required to submit additional information about owners, managing employees and adverse legal actions, as a condition of Medicaid enrollment. States would have to collect and use national provider identifiers for all eligible provider types across enrollment, claims, managed care oversight and program integrity activities.
Senate Democrats question CMS’s Medicaid fraud enforcement approach
While voicing agreement on the need to scrutinize healthcare fraud, Democrats are not on board with some of the Trump administration’s tactics. That could set the stage for clashes after the party assumes the Senate and House majorities in January.
Sen. Ron Wyden (D-Ore.), the ranking member of the Senate Finance Committee and potentially the committee’s chair in the next Congress, co-wrote a Nov. 12 letter to CMS Administrator Mehmet Oz. The letter criticizes deferments in Medicaid funding of more than $2.5 billion for Minnesota and $3.4 billion for California’s home-care program.
“Rather than working with states to fix issues, CMS has replaced on-site reviews and dedicated oversight staff with a public relations ‘War Room’ and unproven artificial intelligence pilots,” according to a news release from Wyden’s office, alleging that “the administration is violating federal law by failing to maintain the minimum required funding and staffing levels for the Medicaid Integrity Program, which was created by Congress to help states fight fraud.”
Wyden and colleagues seek specified documentation and information by Nov. 27.